DXCM NASDAQ
DexCom, Inc.
1W: +24.4%
1M: +13.4%
3M: -1.6%
YTD: +8.1%
1Y: -17.7%
3Y: -39.4%
5Y: -13.7%
$72.10
+0.20 (+0.28%)
Weekly Expected Move ±6.1%
$54
$58
$62
$65
$69
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.67
Bullish
3 bullish
1 neutral
0 bearish
Articles (7d)
4
Daily Sentiment (7 Days)
Articles (100)
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Here's Why DexCom (DXCM) is a Strong Momentum Stock
DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany
Top Quant-rated stocks from Jefferies’ Franchise picks list
Diabetes Tech Player DexCom Lays Out 2030 Growth Vision
Here's Why DexCom (DXCM) is a Strong Value Stock
Catalyst Watch: Cerebras headlines AI-related IPO blitz, CPI print and 13Fs
10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up
PACB Q1 Earnings Beat, Revenues Miss Estimates, Gross Margin Down
QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y
Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates
3 Reasons Analysts Love DexCom
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
ITGR Stock Up Despite Q1 Earnings Missing Estimates, Revenues Rise Y/Y
DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise
BTIG Remains Bullish on DexCom, Inc. (DXCM)
DexCom reiterates $5.16B-$5.25B 2026 revenue outlook while raising operating margin to 23%-23.5%
DexCom (DXCM) Q1 2026 Earnings Transcript
DexCom Q1 2026 Earnings Call Transcript
DexCom (DXCM) Q1 Earnings and Revenues Top Estimates
DexCom Non-GAAP EPS of $0.56 beats by $0.09, revenue of $1.19B beats by $20M
Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline
DexCom (DXCM) is a Top-Ranked Growth Stock: Should You Buy?
Earnings Scheduled For April 30, 2026
2026 Market Cap Madness Championship: Loren v. Emily
Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y
DXCM or MASI: Which Is the Better Value Stock Right Now?
Why DexCom (DXCM) is a Top Value Stock for the Long-Term
Is ISRG's International Weakness a Temporary Drag or Structural Risk?
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
ECL Stock Up in Pre-Market Post In-Line Q1 Earnings, Gross Margin Down
DexCom, Inc. (NASDAQ:DXCM) Receives Average Rating of “Moderate Buy” from Brokerages
Arizona State Retirement System Reduces Stock Position in DexCom, Inc. $DXCM
Anchyra Partners LLC Takes Position in DexCom, Inc. $DXCM
Is DexCom, Inc. (DXCM) A Good Stock To Buy Now?
B. Metzler seel. Sohn & Co. AG Has $2 Million Holdings in DexCom, Inc. $DXCM
Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1?
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
Cwm LLC Sells 91,609 Shares of DexCom, Inc. $DXCM
ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
DXCM STOCKHOLDER NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Investors to Contact the Firm
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom
Chicago Capital LLC Reduces Position in DexCom, Inc. $DXCM
Lbp Am Sa Buys 8,296 Shares of DexCom, Inc. $DXCM
KBC Group NV Sells 133,500 Shares of DexCom, Inc. $DXCM
DexCom, Inc. $DXCM Shares Purchased by Assetmark Inc.
2 Healthcare Stocks That Could Outperform the Market Over the Next Decade
Abbott stock slips on guidance cut, ranks 10th in healthcare equipment Quant ratings
Here's Why You Should Add DexCom Stock to Your Portfolio Now
DexCom (DXCM) Upgraded to Buy: Here's Why
Here's Why DexCom (DXCM) is a Strong Growth Stock
Baillie Gifford & Co. Decreases Stake in DexCom, Inc. $DXCM
DexCom (DXCM) Q2 2025 Earnings Call Transcript
DexCom (DXCM) Q3 2025 Earnings Call Transcript
Exchange Traded Concepts LLC Sells 8,031 Shares of DexCom, Inc. $DXCM
Nisa Investment Advisors LLC Sells 20,529 Shares of DexCom, Inc. $DXCM
Aberdeen Group plc Acquires 43,990 Shares of DexCom, Inc. $DXCM
Banque Pictet & Cie SA Raises Stock Holdings in DexCom, Inc. $DXCM
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Rating of “Moderate Buy” from Analysts
Nasdaq gains from chip, AI-related stocks' recovery after Trump's speech
Compagnie Lombard Odier SCmA Grows Holdings in DexCom, Inc. $DXCM
Bank Pictet & Cie Europe AG Cuts Position in DexCom, Inc. $DXCM
Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves
DexCom, Inc. $DXCM Shares Sold by Beacon Investment Advisory Services Inc.
Notable healthcare headlines for the week: Merck, Medtronic, and Novartis in focus
DAVENPORT & Co LLC Has $1.87 Million Position in DexCom, Inc. $DXCM
GlucoTrack Stock Gains As Data Backs FDA Filing Plans For Glucose Monitoring Tech
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
Assenagon Asset Management S.A. Increases Position in DexCom, Inc. $DXCM
DexCom, Inc. $DXCM Shares Acquired by Gradient Investments LLC
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Novartis in focus
DexCom, Inc. $DXCM Shares Sold by Bank of Nova Scotia
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions
Cinctive Capital Management LP Takes $4.45 Million Position in DexCom, Inc. $DXCM
Bamco Inc. NY Reduces Stock Position in DexCom, Inc. $DXCM
DexCom, Inc. $DXCM Shares Sold by 2Xideas AG
Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term
2 Growth Stocks to Hold for the Next Decade
Here's Why DexCom (DXCM) is a Strong Growth Stock
DexCom, Inc. $DXCM Shares Sold by Alamar Capital Management LLC
Bell Asset Management Ltd Buys Shares of 31,448 DexCom, Inc. $DXCM
DexCom, Inc. (NASDAQ:DXCM) Given Consensus Recommendation of “Moderate Buy” by Analysts
Fisher Asset Management LLC Sells 23,056 Shares of DexCom, Inc. $DXCM
Here's How Much You Would Have Made Owning DexCom Stock In The Last 10 Years
DexCom, Inc. $DXCM Shares Sold by American Century Companies Inc.
111 Capital Buys 10,040 Shares of DexCom, Inc. $DXCM
Andra AP fonden Has $6.25 Million Stock Position in DexCom, Inc. $DXCM
Allianz SE Sells 43,425 Shares of DexCom, Inc. $DXCM
Dexcom Appoints Rick Osterloh to Board of Directors
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars
Dexcom Announces Upcoming Conference Presentation
Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
Brooktree Capital Management Buys 12,635 Shares of DexCom, Inc. $DXCM
DexCom (NASDAQ:DXCM) Stock Acquired Sen. John Boozman
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth